American Portfolios Advisors’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$37.2K Sell
1,325
-600
-31% -$18.6K ﹤0.01% 1873
2022
Q2
$58K Sell
1,925
-550
-22% -$18.9K ﹤0.01% 1678
2022
Q1
$93.8K Sell
2,475
-2,725
-52% -$99.7K ﹤0.01% 1549
2021
Q4
$201K Buy
5,200
+750
+17% +$27.6K 0.01% 1156
2021
Q3
$152K Sell
4,450
-2,700
-38% -$93.3K 0.01% 1255
2021
Q2
$238K Sell
7,150
-225
-3% -$7.52K 0.01% 1038
2021
Q1
$244K Buy
7,375
+3,750
+103% +$129K 0.01% 942
2020
Q4
$114K Buy
+3,625
New +$99.1K 0.01% 1098

Other funds holding BOUT

American Portfolios Advisors's BOUT Position: Q3 2022 in Review

American Portfolios Advisors reduced its CapForce IBD Breakout Opportunities ETF (BOUT) stake by 31% in Q3 2022, selling an estimated $18.6K and leaving 1,325 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1873.

American Portfolios Advisors first reported a position in BOUT in Q4 2020 and has held it in 8 quarters since. The position peaked at $244K in Q1 2021. 10 funds tracked by Wall St. Rank hold BOUT as of Q3 2022.

  • American Portfolios Advisors held 1,325 shares of CapForce IBD Breakout Opportunities ETF worth $37.2K as of Q3 2022.
  • American Portfolios Advisors sold 600 CapForce IBD Breakout Opportunities ETF shares in Q3 2022, an estimated $18.6K.
  • CapForce IBD Breakout Opportunities ETF made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1873 holding.
  • American Portfolios Advisors first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2020 and has held it in 8 quarters since.
  • American Portfolios Advisors's CapForce IBD Breakout Opportunities ETF position peaked at $244K in Q1 2021.
  • 10 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.